The effects of cell cycle inhibition on the expression of the multidrug resistance transporter P-glycoprotein (P-gp) as well as of the cyclin-dependent kinase (CDK) inhibitors p27
Introduction
Although it is well documented that solid tumors in vivo show a proliferative heterogeneity that is correlated to resistance towards chemotherapeutic drugs and radiation, there is yet not su¤cient experimental evidence that tumor cell dormancy is involved in the induction of P-glycoprotein (P-gp) expression. Previous studies suggest that the high percentage of dormant cells in the depth of the tumor tissue may be the main regulator for the development of multidrug resistance (MDR) [1] . In this respect serum starvation, which causes growth arrest in many cell lines, has been demonstrated to induce the expression of the mdr-1 gene in human and mouse tumor cell lines, which was regulated at the transcriptional level in a promoter sequence-speci¢c manner [2] . Consequently, stimulation of cell proliferation induced downregulation of P-gp levels in tumor cells as re-cently evidenced in multicellular prostate tumor spheroids [3] as well as in leukemic blasts [4] . However, it remains unclear so far whether speci¢c cell cycle phases in tumor lesions are correlated with increased expression of P-gp.
Quiescent, proliferation-inactive cell areas occur physiologically in the depth of multicellular tumor spheroids which are a well established in vitro model system for avascular micrometastases and avascular regions of large tumors [5] . In large multicellular tumor spheroids a high expression level of the cyclin-dependent kinase (CDK) inhibitor p27
Kip1 was observed and discussed to play a role as a resistance factor [6] . Overexpression of p27
Kip1 resulted in increase of MDR in transfected cell lines [7] . In contrast, the use of antisense oligonucleotides downregulating p27
Kip1 resulted in the loss of spheroid aggregation and signi¢cant cellular sensitization to alkylating agents [6] . In multicellular prostate tumor spheroids an elevated intrinsic resistance towards the anticancer agent doxorubicin was recently observed with increasing diameter of multicellular spheroids [8] and P-gp identi¢ed as the regulator of resistance [9] . Interestingly, P-gp was found to be expressed predominantly in deeper, quiescent cell layers, indicating that the cell cycle arrest may induce P-gp expression. Additional factors that have been discussed to induce drug resistance in large tumor spheroids may be low pH, hypoxia and central necrosis which are well known to occur in the depth of avascular tumor tissues [10^12] . However, recent results of our group demonstrate that stimulation of cell proliferation in multicellular spheroids by elevation of the intracellular redox state resulted in a signi¢cant downregulation of both P27
Kip1 and P-gp [3, 13] , pointing towards the notion that P-gp expression may be indeed related to speci¢c phases of the cell cycle. The purpose of the present study was to investigate whether the observed P-gp-mediated intrinsic resistance is correlated with cell cycle arrest. Several speci¢c cell cycle inhibitors were administered and P-gp expression as well as the expression of the CDK inhibitors P27 Kip1 and P21 WAFÀ1 were evaluated. Our results show that P-gp is upregulated during G 0 /G 1 but not during G 2 /M arrest and is closely associated to the expression of p27
Kip1 which may be used as tumor marker for intrinsic P-gp-mediated drug resistance.
Materials and methods

Culture technique of multicellular spheroids
The human prostate cancer cell line DU-145 was kindly provided by Dr. J. Carlsson, Uppsala, Sweden. The cells were grown routinely in 5% CO 2 /humidi¢ed air at 37³C with Ham's F10 medium (Gibco Life Technologies, Helgerman Court, MD, USA) supplemented with 10% (v/v) fetal calf serum (Boehringer, Mannheim, Germany), 2 mM glutamine, 0.1 mM L-mercaptoethanol, 2 mM MEM, 100 IU/ml penicillin and 100 Wg/ml streptomycin (ICN Flow, Meckenheim, Germany). Spheroids were grown from single cells. Cell monolayers were enzymatically dissociated with 0.2% (w/v) trypsin, 0.05% (w/v) EDTA (ICN Flow) and seeded in siliconized 250 ml spinner £asks (Tecnomara, Fernwald, Germany) with 250 ml complete medium and agitated at 20 rpm using a Cellspin stirrer system (Integra Biosciences, Fernwald, Germany). Cell culture medium was partially (100 ml) changed every day.
Incubation with cell cycle inhibitors
For incubation with cell cycle inhibitors small multicellular tumor spheroids (diameter 100 þ 50 Wm, day 5) were transferred to bacteriological tissue culture dishes (diameter 10 cm) (Becton Dickinson, Meylan, France) ¢lled with 10 ml F10 cell culture medium. They were subsequently treated either for 24 h with 500 WM mimosine, for 3 h with 30 WM mitomycin C (Sigma, Deisenhofen, Germany), for 24 h with 100 WM roscovitine (Sigma), for 24 h with 20 nM staurosporine (Sigma), or they were cultivated for 24 h under serum starvation. For induction of apoptosis glioma spheroids of the cell line Gli36 were incubated for 3 h with 1 WM staurosporine. For determination of growth curves the compounds were applied for 4 days.
Confocal laser scanning microscopy
Fluorescence recordings were performed by means of a confocal laser scanning setup (LSM 410, Carl Zeiss, Jena, Germany) equipped with an 488 nm argon ion laser and two helium-neon lasers with lines of 543 nm and 633 nm. The confocal setup was con-nected to an inverted microscope (Axiovert 135, Carl Zeiss). Fluorophores were excited using a 0.5 mW helium-neon laser (single excitation at 543 nm). A 25U, N.A. 0.8, oil immersion-corrected objective (Carl Zeiss) was applied. Fluorescence was measured in 3600 Wm 2 areas in a depth of 60 Wm from the spheroid periphery. The thickness of the optical sections amounted to 20 Wm.
Immunohistochemical techniques and quantitative immunohistochemistry
Antibody staining was performed on whole mount multicellular spheroids as well as on single cells enzymatically dissociated from tumor spheroids. The monoclonal antibody (mAb) anti-p27
Kip1 was obtained from Pharmingen (Hamburg, Germany) and was used at a concentration of 2.5 Wg/ml in phosphate-bu¡ered saline supplemented with 0.01% Triton X-100 (Sigma) (PBST) and containing 10% (w/v) fat-free milk powder. The mAb anti-p21 WAFÀ1 was obtained from Pharmingen and was used at a concentration of 5 Wg/ml in Tris-bu¡ered saline (TBS) containing 3% (v/v) FCS. The polyclonal anti-mdr (Ab-1) antibody (Oncogene Research Products, Cambridge, UK) was used at a concentration of 5 Wg/ml in 0.01% PBST. The polyclonal anti-caspase-3 (D-175) antibody (Cell Signaling Technology, Beverly, MA, USA) was used at a dilution of 1/100 in TBS supplemented with 0.1% Triton X-100 (TBST) and containing 5% (v/v) FCS. Spheroids were washed in phosphate-bu¡ered saline (PBS) and were either ¢xed in ice-cold methanol/acetone (7:3) for 1 h (anti-p27 Kip1 ) or in 4% paraformaldehyde in PBS at 4³C for 1 h (anti-p21 WAFÀ1 , anticaspase-3, anti-mdr). Subsequently they were permeabilized with 1% PBST. Prior to immunostaining spheroids were incubated for 1 h in 0.01% PBST containing 10% fat-free milk powder to reduce nonspeci¢c binding. The primary antibody was applied overnight at 4³C (anti-p21 WAFÀ1 , anti-caspase-3) or for 2 h at room temperature (anti-p27
Kip1 , anti-mdr). After washing three times in 0.01% PBST or 0.1% TBST (anti-p21 WAFÀ1 , anti-caspase-3) spheroids were incubated for 60 min in 0.01% PBST supplemented with 10% milk powder and either a Cy5-conjugated F(abP) 2 fragment goat anti-mouse IgG (H+L) (Boehringer-Mannheim) (concentration 3.25 Wg/ml) or a Cy5-conjugated F(abP) 2 fragment goat anti-rabbit IgG (H+L) (Boehringer-Mannheim) (concentration 4.6 Wg/ml). In double labeling experiments with single cells P-gp was labeled by a Cy5-conjugated F(abP) 2 fragment goat anti-rabbit IgG (H+L), whereas p27
Kip1 was labeled by a Cy3-conjugated F(abP) 2 fragment goat anti-mouse IgG (H+L) antibody. Excitation was performed using either a 633 nm or a 543 nm helium-neon laser of the confocal setup. Emission was recorded using either a long pass (LP) LP655 nm or a LP570 nm ¢lter set.
For quantitative immunohistochemistry confocal images of whole mount multicellular spheroids stained with only secondary antibodies (background £uorescence image) and spheroids stained with primary and secondary antibodies were recorded. The pinhole settings of the confocal setup were adjusted to yield optical slices of 20 Wm thickness. After subtraction of background £uorescence the £uorescence signal (counts) was evaluated by the image analysis software of the confocal setup in 3600 Wm 2 areas of interest and routinely exported for further analysis to the Sigma Plot graphic software.
Evaluation of tumor spheroid growth
Tumor spheroids were treated with cell cycle inhibitors for 4 days. The small and large diameters of untreated spheroids or spheroids treated with agents as described above were determined. Spheroid volumes were calculated according to V = 4/3WZWaWb 2 , where a represents the large half axis and b the small half axis of the respective tumor spheroid. The growth of tumor spheroids was evaluated every 24 h.
Determination of cell cycle
The DNA content of cells from each preparation was determined by £ow cytometry (Calibur Cytometer, Becton Dickinson, Heidelberg, Germany) analysis after staining the nuclei with propidium iodide. Prior to staining multicellular spheroids were dissociated to gain a single cell suspension using trypsin/ EDTA for 5 min at 37³C. Following centrifugation the cell pellet was washed three times with citrate bu¡er (0.25 M sucrose, 0.04 M sodium citrate, 5% v/v DMSO, pH 7.6, 4³C). The cells were stained using the Cycle TEST PLUS DNA Reagent Kit (Bec-ton Dickinson) according to the supplier's manual. In principle, cell membrane lipids were dissolved with a non-ionic detergent, cell cytoskeleton and nuclear proteins were eliminated with trypsin and cellular RNA was digested with RNase prior to staining with propidium iodide. The preparations were kept on ice in the dark until £ow cytometry analysis was performed. Propidium iodide £uorescence was excited with an argon ion laser (488 nm) and the emitted £uorescence light between 564 and 606 nm was analyzed using a 585/42 band pass ¢lter. To analyze the data the Cell Quest Programm (Becton Dickinson) was used.
Determination of cell lethality with SYTOX
After 24 h of incubation with cell cycle inhibitors the medium was exchanged for fresh F10 medium supplemented with 1 WM SYTOX green (Molecular Probes, Eugene, OR, USA) which intensively stains the nuclei of cells with compromised cell membranes. Following 1 h of incubation the percentage of labeled lethal cells was assessed using the 488 nm band of the argon laser of the confocal setup and a long pass LP515 nm ¢lter set.
Determination of intracellular reactive oxygen species (ROS) levels
Intracellular ROS levels were measured using the £uorescent dye 2P,7P-dichlorodihydro£uorescein diacetate (H 2 DCFDA) (Molecular Probes), which is a non-polar compound that is converted into a non£uorescent polar derivative (H 2 DCF) by cellular esterases after incorporation into cells. H 2 DCF is membrane impermeable and is rapidly oxidized to the highly £uorescent 2P,7P-dichloro£uorescein (DCF) in the presence of intracellular ROS [14] . 10, HEPES 10 (pH 7.4 at 23³C) and 20 WM H 2 DCFDA dissolved in dimethyl sulfoxide (DMSO) was added. After 5, 10, 15, 20, and 30 min intracellular DCF £uorescence (corrected for background £uorescence) was evaluated in 3600 Wm 2 regions of interest using an overlay mask. For £uorescence excitation, the 488 nm band of the argon ion laser of the confocal setup was used. Emission was recorded using a long pass LP515 nm ¢lter set.
Statistical analysis
Data are given as mean values þ S.D., with n denoting the number of experiments. In each experiment, at least 20 multicellular spheroids were analyzed. Student's t-test for unpaired data was applied as appropriate. A value of P 6 0.05 was considered signi¢cant.
Results
Distribution of speci¢c cell cycle phases in multicellular tumor spheroids
Multicellular spheroids of di¡erent size classes and age were enzymatically dissociated and the distribution of cell cycle phases was investigated by £ow cytometry analysis (Figs. 1A^D and 2A^C) (n = 3). The number of cells in the G 0 /G 1 phase of the cell cycle increased from 49 þ 0.2% to 73 þ 2% in 1^3-day-old and 20^30-day-old multicellular spheroids, respectively. The number of cells in the S phase of the cell cycle was maximum in 1^3-day-old multicellular spheroids with 24 þ 1% and declined with increasing age of the spheroid culture to a minimum of 13 þ 2% in multicellular spheroids between days 15 and 19. In parallel, the number of cells in the G 2 /M phase declined from 27 þ 1% in 1^3-day-old multicellular spheroids to a minimum of 13 þ 2% in 20^30-dayold multicellular spheroids.
Correlation of p27
Kip1 and P-gp expression in DU-145 tumor spheroids
We have previously evidenced in whole mount multicellular tumor spheroids that with increasing size and age of the spheroid culture the cell quiescence-associated CDK inhibitors p27 Kip1 and p21 WAFÀ1 were upregulated whereas the proliferative antigen Ki-67 was downregulated [13] . Furthermore, the increase in the fraction of G 0 /G 1 phase cells during the time course of tumor spheroid culture was paralleled by an increase in P-gp expression (Fig. 3A) . To demonstrate the correlation of p27
Kip1 and P-gp on the single cell level, small (1^3-day-old) as well as large (15^19-day-old) tumor spheroids were enzymatically dissociated and the expression levels of p27
Kip1 and P-gp were evaluated by double-label immunohistochemistry and confocal laser scanning microscopy. As shown in Fig. 3C a signi¢cant proportion of cells dissociated from large tumor spheroids displayed elevated levels of p27 as well as P-gp expression, indicating that these cells may be arrested in the G 0 /G 1 phase of the cell cycle (n = 3). By contrast, in cells derived from exponentially growing small tumor spheroids expression of p27
Kip1 as well as P-gp was marginal (see Fig. 3B ) (n = 3), which supports the notion of the present study that P-gp expression may be correlated with cell cycle arrest.
Cell cycle phases upon treatment of tumor spheroids with cell cycle inhibitors
To investigate the possible correlation of speci¢c cell quiescence-associated cell cycle phases and P-gp expression in more detail, various cell cycle inhibitors which cause cell cycle arrest at speci¢c phases were applied to multicellular spheroids at an age (5-day- Kip1 and P-gp expression in single cells enzymatically dissociated from small (3-day-old) (B) and large (19-day-old) tumor spheroids (C). Enzymatically dissociated single cells were double-labeled by antibodies directed against p27
Kip1 and P-gp and protein expression was evaluated by confocal laser scanning microscopy. Shown is one representative of three experiments which yielded comparable results. old) just prior to the induction of cell quiescence in the depth of the tumor tissue. Multicellular spheroids at day 5 of spheroid culture (diameter 100 þ 50 Wm) expressing marginal levels of P-gp [3, 9] were treated with either mimosine (500 WM), mitomycin C (30 WM), roscovitine (100 WM), staurosporine (20 nM) or serum-free conditions for 4 days. Under serumfree conditions and upon treatment with staurosporine cells are known to be arrested in the G 0 /G 1 phase of the cell cycle [15] ; mimosine has been previously reported to induce G 0 /G 1 arrest by enhancing the levels of p27
Kip1 [16] ; mitomycin has been recently evidenced to inhibit S phase progression [17] , and roscovitine inhibits the cyclin-dependent kinases CDK2 as well as cdc2 and arrests the cell cycle in the G 2 /M phase [18] . Every 24 h mean diameters of spheroids were recorded and the relative volume increase was calculated. As shown in Fig. 4A , the growth kinetics were signi¢cantly reduced in all treated samples as compared to the untreated controls (n = 3). In parallel experiments cell lethality was assessed using the lethal cell stain SYTOX green (1 WM). No cell lethality occurred upon treatment with cell cycle inhibitors (data not shown). Moreover, immunohistochemistry with anti-caspase-3 revealed that within 24 h no induction of apoptosis occurred (Fig. 4B ) (n = 3). As a positive control for anti-caspase-3, multicellular tumor spheroids of the glioma cell line Gli36 staining were incubated with 1 WM staurosporine for 3 h which resulted in pronounced apoptosis with approx. 200% increase in immuno£uorescence (Fig. 4B, insert) .
To obtain further information on the speci¢c phases in the cell cycle where cell cycle arrest occurred upon treatment with cell cycle inhibitors, a £ow cytometry analysis was performed (Fig. 5) . Small tumor spheroids (5-day-old) were transferred to bacteriological Petri dishes and incubated for 24 h with either mimosine, roscovitine, staurosporine, serum-free medium, or for 3 h with mitomycin C. After propidium iodide staining of cellular DNA and £ow cytometry analysis the cell cycle distribution in the control sample of multicellular spheroids in liquid overlay culture was determined to 65 þ 3% cells in G 0 /G 1 phase, 15 þ 2% cells in S phase and 20 þ 1% cells in G 2 /M phase (n = 4). Treatment with either mimosine, serum-free conditions or staurosporine increased the percentage of cells in the G 0 /G 1 cell cycle phase to 75 þ 5%, 78 þ 3% and 79 þ 2%, respectively (n = 3). Treatment of tumor spheroids with roscovitine as well as mitomycin C increased the number of cells in the S phase of the cell cycle to 27 þ 5% and Fig. 4 . Growth kinetics (A) and apoptosis (B) in multicellular DU-145 spheroids following treatment with mimosine, mitomycin C, roscovitine, serum-free medium and staurosporine. Note that all applied cell cycle inhibitors signi¢cantly depressed tumor spheroid growth as compared to the untreated control. No signs of apoptosis induction as evaluated by anti-caspase-3 immunohistochemistry were observed in prostate tumor spheroids which were treated with cell cycle inhibitors. As positive control Gli36 glioma spheroids were treated with 1 WM staurosporine for 3 h to induce apoptosis (insert). *P 6 0.05, signi¢cantly different from the untreated control.
22 þ 7%, respectively. Arrest in the G 2 /M phase of the cell cycle with 30.5 þ 8% of total cells (n = 4) was achieved upon treatment of tumor spheroids with roscovitine.
Expression of the CDK inhibitors p27
Kip1 and p21 WAF À1 following treatment of tumor spheroids with cell cycle antagonists Cell cycle arrest induced by pharmacological agents may alter the expression of p27
Kip1 and p21 WAFÀ1 , thereby abrogating progression through the cell cycle. To investigate this issue 5-day-old tumor spheroids were incubated for 24 h with cell cycle inhibitors and the expression of p27 Kip1 (Fig. 6A,B ) and p21 WAFÀ1 (Fig. 7A,B) was investigated by quantitative immunohistochemistry. Treatment of tumor spheroids with either mimosine or incubation in serum-free cell culture medium signi¢cantly increased the level of p27
Kip1 to 127 þ 5% and 166 þ 7%, respectively (n = 3), whereas upon treatment with staurosporine p27
Kip1 levels remained unchanged (untreated control set to 100%). The expression of p27 Kip1 was signi¢cantly decreased to 78 þ 3% and 89 þ 4% in the roscovitine-and mitomycin C-treated samples, respectively (n = 3). In contrast, the level of p21 WAFÀ1 remained unchanged in the mimosinetreated sample and was signi¢cantly increased to 131 þ 7% and 123 þ 4% upon incubation of tumor spheroids in serum-free cell culture medium and staurosporine, respectively (n = 3). Roscovitine and mitomycin C treatment resulted in a signi¢cant downregulation of p21 WAFÀ1 to 87 þ 3% and to 82 þ 3%, respectively (n = 3).
Expression of P-gp following treatment of multicellular tumor spheroids with cell cycle inhibitors
To correlate the cell cycle arrest at di¡erent states of the cell cycle with the level of P-gp, changes of Pgp expression were investigated after treatment with either mimosine, mitomycin C, roscovitine, or incubation in serum-free cell culture medium (Fig. 8) . In parallel to the observed elevation in the expression of p27
Kip1 (see Fig. 6 ) the expression of P-gp was signi¢cantly increased to 136 þ 8% in the mimosinetreated sample and to 144 þ 13% in the serum-free treated sample, whereas staurosporine, which comparably to mimosine and serum-free conditions arrested cells in the G 0 /G 1 phase, signi¢cantly downregulated P-gp expression to 64 þ 14% of the control (n = 4) (untreated control set to 100%). Upon treatment with mitomycin C and roscovitine the P-gp level remained unchanged (n = 4).
Elevation of intracellular ROS and redoxsensitive regulation of P-gp by staurosporine
The data of the present study demonstrate that staurosporine downregulated P-gp expression although this agent is known to induce G 0 /G 1 arrest. By contrast our data with mimosine and serum-free Kip1 immuno£uorescence in multicellular tumor spheroids treated with cell cycle inhibitors. Note that p27
Kip1 expression was increased in the samples treated with mimosine and serum-free medium. *P 6 0.05, signi¢cantly different from the untreated control. medium show that G 0 /G 1 arrest induced by these compounds resulted in an upregulation of P-gp. Previous studies of our group suggested that P-gp expression is regulated by ROS [3, 13] . Furthermore, staurosporine has been recently shown to elevate the intracellular ROS levels [19] . To investigate whether the downregulation of P-gp by staurosporine was owing to an elevation of ROS, the intracellular redox state was evaluated by the use of the redox-sensitive dye H 2 DCFDA. As shown in Fig. 9A staurosporine signi¢cantly increased the oxidation kinetics of H 2 DCF to £uorescent DCF, indicating an increased rate of ROS generation (n = 3). By contrast neither roscovitine, mitomycin C and mimosine WAFÀ1 expression was signi¢cantly increased in the samples treated with serum-free conditions and staurosporine. *P 6 0.05, signi¢cantly di¡erent from the untreated control. treatment nor incubation in serum-free medium signi¢cantly altered intracellular ROS levels (data not shown).
If the downregulation of P-gp was caused by an elevation of intracellular ROS, an inhibition of ROS generation by coadministration of free radical scavengers should abrogate the observed e¡ect. To evaluate this point multicellular tumor spheroids were preincubated with the free radical scavenger ebselen (1 WM) prior to the addition of staurosporine. This treatment completely abolished the downregulation of P-gp following incubation with staurosporine ( Fig. 9B) (n = 3) , indicating that the e¡ect of staurosporine on P-gp expression was medi- ated by its property to elevate intracellular ROS levels.
Discussion
Intensive e¡orts have been undertaken in recent years to discover new drugs targeting the cell cycle as potential therapeutics of cancer [20, 21] . In general, highly proliferative cells are more sensitive towards chemotherapy. This has been achieved by the development of anticancer drugs which interfere with cell cycle progression on di¡erent levels, e.g. through inhibition of mitogen activated protein kinase pathways [22] , inhibition of cyclin-dependent protein kinases [23] , accumulation in the G 2 /M phase of the cell cycle owing to the induction of DNA strand breaks [24] , as well as intercalation into the DNA during the S phase of the cell cycle [25] . However, with increasing size most solid tumors in vivo develop a proliferative heterogeneity in tumor regions with limited angiogenesis as a result of hypoxia and insu¤cient nutrient supply. Commonly, the proliferative heterogeneity is accompanied by an increased resistance to chemotherapeutic drugs in subpopulations of the tumor and an upregulation of CDK inhibitors which interfere with the progression of the cell cycle [26] .
The CDK inhibitor P27 Kip1 , which is predominantly expressed in cells with tight intercellular contact, has been proposed as a resistance factor since upregulation of p27
Kip1 coincided with the occurrence of drug resistance [6] . This assumption was validated by the use of antisense oligonucleotides to downregulate P27
Kip1 which resulted in loss of aggregation and a signi¢cant increase in the sensitivity to alkylating agents [6] . In line with these ¢ndings previous studies of our group suggested a correlation between elevated P27 Kip1 expression and the appearance of a MDR phenotype, since MDR was predominantly detected in quiescent cell areas which displayed a parallel expression of p27
Kip1 and P-gp [3, 9, 13] . Therefore, it had to be investigated whether the cell quiescence-related increase in P-gp expression was generally owing to a decrease in the proliferation rate of tumor cells in the depth of the three-dimensional tumor tissue, or whether cell cycle arrest in a speci¢c phase of the cell cycle was a prerequisite for P-gp induction.
To address these issues several known cell cycle inhibitors which arrest the cell cycle at speci¢c phases were applied to exponentially growing tumor spheroids, and subsequently the expression levels of P-gp as well as of the CDK inhibitors p27
Kip1 and p21 WAFÀ1 were investigated. Using the plant amino acid mimosine, it was shown that a signi¢cant stimulation of p27 Kip1 expression as well as an increase in Fig. 9 . Elevation of intracellular ROS by staurosporine (A) and ROS-mediated downregulation of P-gp (B). Endogenous generation of ROS was investigated using the redox-sensitive dye H 2 DCFDA. The DCF £uorescence increase was recorded for 30 min. The £uorescence value at 30 min in every control measurement was set to 100% and was set in relation to the staurosporine-treated sample. The downregulation of P-gp expression in B following treatment for 24 h with staurosporine was abolished after coadministration of the free radical scavenger ebselen, indicating that the observed e¡ect was owing to the enhancement of ROS generation by this compound. *P 6 0.05, signi¢cantly di¡erent from the untreated control.
P-gp levels occurred, whereas the expression level of p21 WAFÀ1 remained unchanged. This is in line with the observation of a recent study demonstrating that mimosine arrests cells at the G 1 /S border by enhancing the levels of p27
Kip1 [16] . Serum starvation, which causes a general arrest of cells in the G 0 /G 1 phase [27] , elevated the levels of both p27
Kip1 and p21 WAFÀ1 and increased the expression level of P-gp. In a reporter gene assay it has been previously demonstrated that serum starvation directly activated the MDR-1 promoter [2] . In the present study mitomycin C, which inhibits S phase progression in Rb (+/+) mouse embryo ¢broblasts [17] , signi¢cantly decreased the expression of p27
Kip1 as well as p21 WAFÀ1 , whereas P-gp levels remained unchanged. This is in contrast to a recent study which demonstrated a downregulation of MDR-1 mRNA as well as P-gp levels following treatment of xenografted P-gp overexpressing cells with non-cytotoxic doses of mitomycin C [28] . Roscovitine, a potent and selective inhibitor of cyclin-dependent kinases cdc2 and Cdk2, induces changes in cell cycle distribution. Using £ow cytometry analysis a recent study evidenced a decrease in the number of S phase cells in parallel to an increase in the number of G 2 /M phase cells [18] . Comparable results, i.e. an increase in the number of cells in the S phase as well as in the G 2 /M phase, were achieved in the present study. Furthermore, it was observed that roscovitine treatment decreased p27
Kip1 and p21 WAFÀ1 levels, whereas the P-gp expression remained unchanged. Apparently pharmacological inhibition of Cdk2 resulted in downregulation of endogenous physiological Cdk2 inhibitors, i.e. p27
Kip1 and p21 WAFÀ1 . Our data conclusively evidence that upregulation of p27 Kip1 in multicellular spheroids is paralleled by an increased P-gp expression, corroborating the function of p27
Kip1 as a resistance factor [6] . However, downregulation of p27
Kip1 did not inevitably result in a loss of P-gp expression, since downregulation of p27 Kip1 by roscovitine as well as mitomycin C treatment did not a¡ect P-gp expression. The data of the present study indicate that cell cycle arrest is not generally regulating P-gp since cell cycle arrest in the G 2 /M and in the S phase of the cell cycle did not a¡ect P-gp expression. Furthermore, staurosporine treatment downregulated P-gp although it arrested the G 0 /G 1 phase of the cell cycle comparably to mimosine and serum-free cell culture medium. The downregulation of P-gp by staurosporine was apparently owing to the previously reported generation of ROS via the mitochondrial respiratory chain [19] . Inhibition of P-gp function following treatment of drugresistant cells with staurosporine has previously been reported but was attributed to the inhibition of protein kinase C (PKC) activity which is required for the phosphorylation and activation of P-gp [29^31]. There is also evidence for a circumvention of P-gp-mediated MDR by staurosporine independent of PKC activity [32, 33] , which may be related to downregulation of MDR-1 mRNA and P-gp expression [34] .
Previous studies of our group suggest that P-gp expression in multicellular prostate tumor spheroids is regulated by the intracellular redox state which is maintained by the balance between ROS generation and the activity of the antioxidant defense system [3, 13] . Low concentrations of ROS which induced cell proliferation downregulated P-gp as well as p27
Kip1 expression. Hence it sounds reasonable that under stress conditions which are present in hypoxic, avascular microregions of tumors p27
Kip1 contributes to a cell cycle arrest that is essential for cell survival, whereas P-gp contributes to cell survival by its property to detoxify the tissue from catabolic waste products. Thus, possible roles of p27
Kip1 and P-gp may be to coordinate cell cycle, cell death and detoxi¢cation programs in order to protect cells from external insults which may explain the parallel expression of both proteins observed in multicellular tumor spheroids.
